CheMOnitor

Predicting the effectiveness of chemotherapy in lung cancer patients

Latest news

Latest news

CheMonitor Joins the EIT Jumpstarter 2025 Journey!

We’re proud to announce that CheMonitor has been selected to participate in the EIT Jumpstarter 2025 programme! Among hundreds of applicants, our healthcare innovation stood out and earned a spot in this prestigious EU initiative. Over the next 7 months, we’ll engage in intensive training, expert mentoring, and international networking as part of the Healthcare cohort. This marks an exciting step forward in bringing our diagnostic solution to life—driven by knowledge, collaboration, and a shared vision for impact.

Partners

Let's create something extraordinary together

We are seeking strategic investors with experience in the medtech and deeptech sectors to support our next phase of growth.

Investment amount

From €500,000 (as sole investor or co-investor)

In exchange for

Equity in a high-potential technology company

Investment opportunity

Ready to shape the future of innovation with us?